Chesnara plc (LON:CSN)
London · Delayed Price · Currency is GBP · Price in GBX | Market Cap | 771.77M +19.5% |
| Revenue (ttm) | 342.80M -7.8% |
| Net Income | -10.40M |
| EPS | -0.05 |
| Shares Out | 231.07M |
| PE Ratio | n/a |
| Forward PE | 14.17 |
| Dividend | 0.23 (6.62%) |
| Ex-Dividend Date | Apr 2, 2026 |
| Volume | 428,980 |
| Open | 337.50 |
| Previous Close | 340.00 |
| Day's Range | 332.50 - 340.96 |
| 52-Week Range | 264.60 - 352.00 |
| Beta | 0.52 |
| Analysts | Buy |
| Price Target | 362.80 (+8.62%) |
| Earnings Date | Aug 25, 2026 |
About Chesnara
Chesnara plc, together with its subsidiaries, operates in life assurance and pension businesses primarily in the United Kingdom, Sweden, and the Netherlands. It underwrites life, health, accident, and disability cover by providing savings and pensions products to meet future financial needs; and provides a portfolio of investment contracts. The company also provides term life, unit-linked, index-linked, and non-linked business products. It distributes its products principally through independent financial advisers. Chesnara plc was incorporated... [Read more]
Financial Performance
Financial StatementsAnalyst Summary
According to 5 analysts, the average rating for CSN stock is "Buy." The 12-month stock price target is 363p, which is an increase of 8.62% from the latest price.
News
Chesnara price target lowered to 360 GBp from 370 GBp at RBC Capital
RBC Capital analyst Mandeep Jagpal lowered the firm’s price target on Chesnara (CSNRF) to 360 GBp from 370 GBp and keeps an Outperform rating on the shares. Published first on…
Chesnara price target raised to 339 GBp from 333 GBp at Berenberg
Berenberg raised the firm’s price target on Chesnara (CSNRF) to 339 GBp from 333 GBp and keeps a Buy rating on the shares.
Chesnara Earnings Call Transcript: H2 2025
Strong financial and operational performance was delivered, with major acquisitions boosting future cash flows and assets under administration. Solvency and leverage remain robust, supporting further M&A and dividend growth, while management actions and AI adoption drive efficiency.
Chesnara Annual report: H2 2025
Chesnara has published its H2 2025 annual report on March 24, 2026.
Chesnara Slides: H2 2025
Chesnara has posted slides in relation to its H2 2025 quarterly earnings report, which was published on March 24, 2026.
Chesnara Annual report: H2 2025
Chesnara has published its H2 2025 annual report on March 24, 2026.
Chesnara Slides: Investor presentation
Chesnara has posted slides in relation to its latest quarterly earnings report, which was published on March 10, 2026.
Chesnara Transcript: M&A announcement
The acquisition of Scottish Widows Europe adds EUR 250 million in lifetime cash generation and strengthens the group’s position in the European market. The deal is value accretive, supports dividend growth, and enhances future M&A capacity, with integration expected by year-end.
Chesnara Press release: M&A announcement
Chesnara issued a press release on February 17, 2026, disclosing material business information to investors.
Chesnara Slides: M&A announcement
Chesnara has posted slides in relation to its latest quarterly earnings report, which was published on February 17, 2026.
Chesnara Earnings Call Transcript: H1 2025
Strong H1 2025 results featured 26% higher cash generation, a 4-point solvency ratio increase, and a 3% interim dividend hike. The HSBC Life U.K. acquisition and capital raises will boost scale, financial flexibility, and M&A capacity.
Chesnara Quarterly report: H1 2025
Chesnara has published its H1 2025 quarterly earnings report on August 28, 2025.
Chesnara Slides: H1 2025
Chesnara has posted slides in relation to its H1 2025 quarterly earnings report, which was published on August 28, 2025.